National Drug Strategy
National Drug Strategy

National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence: abbreviated version

Print page  Decrease text size  Increase text size

Abbreviated version of guidelines to assist medical practitioners in the safe and effective provision of buprenorphine treatment in Australia.

PDF printable version of National clinical guidelines for the use of buprenorphine in the treatment of opioid dependence: abbreviated version (PDF 850 KB large file)

The same publication in smaller sections:

Cover page (PDF 401 KB)
Abbreviated report (PDF 397 KB)

The detailed guidelines are available at:
National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence

Page currency, Latest update: October, 2006

Help with accessing large documents

When accessing large documents (over 500 KB in size), it is recommended that the following procedure be used:

  1. Click the link with the RIGHT mouse button
  2. Choose "Save Target As.../Save Link As..." depending on your browser
  3. Select an appropriate folder on a local drive to place the downloaded file

Attempting to open large documents within the browser window (by left-clicking) may inhibit your ability to continue browsing while the document is opening and/or lead to system problems.

Help with accessing PDF documents

To view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. A number of PDF readers are available through the Australian Government Information Management Office (AGIMO) Web Guide website.